In particular, ferroptosis can be enhanced by ALOX15 and ALOX12 activation as downstream effectors of the p53 pathway, which, in turn, can cause SLC7A11 inhibition in H1299 lung cancer cells (Chu et al., 2019; Ou et al., 2016). The gene discussed is TP53; the disease is lung carcinoma.